AZERUTAMIG
UNII 7DGR11S93X

Substance Identification & Data

This profile provides standardized clinical and technical data for Azerutamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7DGR11S93X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2920336-42-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7DGR11S93X
CAS Registry Number
2920336-42-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AZERUTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13130
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azerutamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AZERUTAMIG

Common Names & Synonyms

AZERUTAMIG [INN]
HETERODIMERIC MULTI-SPECIFIC IGG1 ANTIBODY TARGETING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) AND NKG2D ON NATURAL KILLER (NK) AND CYTOTOXIC T-CELLS
IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_SCFVKH-H-GAMMA1(H-CH2-CH3), ANTI-(HOMO SAPIENS KLRK1 (KILLER CELL LECTIN LIKE RECEPTOR K1, NKG2D, KLR, NKG2-D, CD314)) AND ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185CERBB2, NEU, CD340)), HOMO SAPIENS AND HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC

Technical Codes

DF1001
DF-1001